Table 2.
Characteristic | HIV |
HCV |
||||||
---|---|---|---|---|---|---|---|---|
Overall, N = 11,562a | Pre, N = 2640a | Intervention, N = 5129a | Post, N = 3793a | Overall, N = 2410a | Pre, N = 268a | Intervention, N = 1221a | Post, N = 921a | |
Age category | ||||||||
18–24 | 2219 (19%) | 558 (21%) | 970 (19%) | 691 (18%) | 258 (11%) | 24 (9.0%) | 136 (11%) | 98 (11%) |
25–29 | 2239 (19%) | 544 (21%) | 984 (19%) | 711 (19%) | 259 (11%) | 32 (12%) | 115 (9.4%) | 112 (12%) |
30–39 | 2995 (26%) | 684 (26%) | 1259 (25%) | 1052 (28%) | 462 (19%) | 56 (21%) | 235 (19%) | 171 (19%) |
40–49 | 1740 (15%) | 357 (14%) | 800 (16%) | 583 (15%) | 353 (15%) | 46 (17%) | 164 (13%) | 143 (16%) |
50–59 | 1300 (11%) | 273 (10%) | 612 (12%) | 415 (11%) | 410 (17%) | 43 (16%) | 207 (17%) | 160 (17%) |
>60 | 1069 (9.2%) | 224 (8.5%) | 504 (9.8%) | 341 (9.0%) | 668 (28%) | 67 (25%) | 364 (30%) | 237 (26%) |
Sex at birth | ||||||||
Female | 6468 (56%) | 1411 (53%) | 2954 (58%) | 2103 (55%) | 1358 (56%) | 137 (51%) | 704 (58%) | 517 (56%) |
Male | 5094 (44%) | 1229 (47%) | 2175 (42%) | 1690 (45%) | 1052 (44%) | 131 (49%) | 517 (42%) | 404 (44%) |
Ethnicity/race | ||||||||
Hispanic/Latino | 1375 (12%) | 316 (12%) | 624 (12%) | 435 (11%) | 243 (10%) | 24 (9.0%) | 141 (12%) | 78 (8.5%) |
Non-Hispanic Black/African American | 623 (5.4%) | 155 (5.9%) | 297 (5.8%) | 171 (4.5%) | 146 (6.1%) | 24 (9.0%) | 65 (5.3%) | 57 (6.2%) |
Non-Hispanic White | 408 (3.5%) | 94 (3.6%) | 180 (3.5%) | 134 (3.5%) | 120 (5.0%) | 10 (3.7%) | 69 (5.7%) | 41 (4.5%) |
Other/unknown | 9156 (79%) | 2075 (79%) | 4028 (79%) | 3053 (80%) | 1901 (79%) | 210 (78%) | 946 (77%) | 745 (81%) |
Hospital setting | ||||||||
Academic | 8459 (73%) | 1975 (75%) | 3839 (75%) | 2645 (70%) | 1727 (72%) | 217 (81%) | 844 (69%) | 666 (72%) |
Community | 3103 (27%) | 665 (25%) | 1290 (25%) | 1148 (30%) | 683 (28%) | 51 (19%) | 377 (31%) | 255 (28%) |
Testing for the first time | ||||||||
Yes | 6733 (58%) | 1530 (58%) | 3021 (59%) | 2182 (58%) | 1510 (63%) | 162 (61%) | 755 (62%) | 593 (65%) |
No | 4810 (42%) | 1110 (42%) | 2093 (41%) | 1607 (42%) | 888 (37%) | 103 (39%) | 464 (38%) | 321 (35%) |
Positive cases | 93 (0.82%) | 25 (0.96%) | 35 (0.69%) | 33 (0.91%) | 272 (3.5%) | 46 (7.5%) | 121 (2.8%) | 105 (3.5%) |
Patient screened in ED per week | 127 (5.4%) | 88 (3.8%) | 171 (7.3%) | 122 (5.1%) | 88 (3.7%) | 21 (0.87%) | 144 (6.1%) | 100 (4.2%) |
Average patient visit by week | 128 | 88 | 171 | 126 | 27 | 9 | 41 | 31 |
n (%).
Pre-intervention period: March 1, 2018 through September 26, 2018.
Intervention period: September 27, 2018 through April 24, 2019.
Post-intervention period: April 25, 2019 through November 20, 2019.
ED, emergency department; HCV, hepatitis C virus.